Cagrilintide is a long-acting amylin receptor agonist investigated for its role in metabolic signaling, appetite regulation, and energy balance pathways. As a synthetic analog designed to mimic the activity of naturally occurring amylin, Cagrilintide has become an area of growing scientific interest in preclinical and pharmaceutical research focused on metabolic function and peptide-based therapeutic development. Cargilintide is strictly for research use only and not intended for human or animal consumption.